Menu
PacPremier
Magic Hour
Montecito
SoCal Gas
Loading...
You are here:  Home  >  'Amgen'  -  Page 40
Latest

Amgen updates agreement with DaVita for dialysis treatment

By   /  Monday, January 9th, 2017  /  Central Coast Health Watch, Latest news, Tri-County Public Companies  /  Comments Off on Amgen updates agreement with DaVita for dialysis treatment

Thousand Oaks biotech company Amgen entered into a six-year supply agreement with DaVita for dialysis treatments, the company announced on Jan. 9. Under the terms of the new agreement, Amgen will supply DaVita with Epogen and Aranesp for agents to stimulate red blood cells in dialysis treatment in the United States and Puerto Rico. The Read More →

Read More →
Latest

Amgen partners with Immatics Biotechnologies to develop cancer drugs

By   /  Monday, January 9th, 2017  /  Central Coast Health Watch, Latest news, Tri-County Public Companies  /  Comments Off on Amgen partners with Immatics Biotechnologies to develop cancer drugs

Thousand Oaks biotech company Amgen formed a potential $500 million partnership with Immatics Biotechnologies GmbH to research and develop next-generation, T-cell engaging bispecific immunotherapies targeting multiple cancers, the company announced on Jan. 9. Under the terms of the agreement, Immatics will receive $30 million upfront and can receive more than $500 million in development, regulatory Read More →

Read More →
Latest

Amgen shares climb after judge upholds Repatha patents

By   /  Friday, January 6th, 2017  /  Central Coast Health Watch, Latest news, Law  /  Comments Off on Amgen shares climb after judge upholds Repatha patents

A ruling in a patent law case regarding a new anti-cholesterol drug involving Thousand Oaks biotech giant Amgen has skyrocketed Amgen shares. Amgen filed a patent infringement lawsuit against Sanofi and Regeneron in the U.S. District Court of Delaware in October 2014 to block the development and sale of the drug Praluent, which was developed Read More →

Read More →
Latest

Corporate tax cut could fuel biotech mergers, acquisitions

By   /  Friday, January 6th, 2017  /  Central Coast Health Watch, East Ventura County, left, Technology, Tri-County Economy  /  Comments Off on Corporate tax cut could fuel biotech mergers, acquisitions

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Legislators should help manufacturing rebound

By   /  Friday, December 23rd, 2016  /  Editorials, Latest news, Opinion  /  Comments Off on Legislators should help manufacturing rebound

While the South Coast is reveling in its waterfront makeover, tri-county tourism is getting stronger and economists are heralding a boom in craft spirits, the manufacturing core of the region is looking more and more hollowed-out. Large sections of Simi Valley and west Ventura County and North Santa Barbara County are losing head-of-household jobs. San Read More →

Read More →
Latest

Amgen seeks to market osteoporosis drug in Japan

By   /  Tuesday, December 20th, 2016  /  Central Coast Health Watch, Latest news, Technology  /  Comments Off on Amgen seeks to market osteoporosis drug in Japan

Thousand Oaks biotech giant Amgen is seeking marketing approval in Japan for osteoporosis drug romosozumab, the company announced on Dec. 20. Amgen submitted the request to the Pharmaceuticals and Medical Devices Agency in Japan, where an estimated 12 million people have a high risk of bone fracture. The company is co-developing the drug worldwide with Euronext Read More →

Read More →
Latest

Tri-county companies self-insure employee health care coverage

By   /  Friday, November 25th, 2016  /  Central Coast Health Watch, Latest news  /  Comments Off on Tri-county companies self-insure employee health care coverage

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →